InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,306.04
(
0.02%
)
US TECH 100
18,387.60
(
0.38%
)
Dow Jones
38,852.86
(
-0.55%
)
Brent Oil
84.20
(
-0.15%
)
Bitcoin
68,257.89
(
-0.05%
)

Replies to post #515 on Trillium Therapeutics Inc (TRIL)

Replies to #515 on Trillium Therapeutics Inc (TRIL)

ronpopeil

12/03/16 2:17 PM

#516 RE: NY1972 #515

Agreed. There was also Impressive preclinical data for anti-CD47 + rituximab for lymphoma.